Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Experimental and Molecular Pathology
|
May 21, 2009
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Abdullah Yalcin, Sucheta Telang, Brian Clem, et al.
The Biochemical Journal
|
January 25, 2008
The Rb/E2F pathway and Ras activation regulate RecQ helicase gene expression
Yongqing Liu, Shahenda El-Naggar, Brian Clem, et al.
Cancer & Metabolism
|
January 24, 2014
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism
Alden C Klarer, Julie O'Neal, Yoannis Imbert-Fernandez, et al.
Nature Communications
|
October 24, 2013
Rb1 family mutation is sufficient for sarcoma initiation
Yongqing Liu, Ester Sánchez-Tilló, Xiaoqin Lu, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Remote organ cancer adversely alters renal function and induces kidney injury, inflammation, and fibrosis
Dana Hammouri, Andrew Orwick, Mark Doll, et al.
American Journal of Physiology. Renal Physiology
|
December 16, 2024
Remote organ cancer induces kidney injury, inflammation, and fibrosis and adversely alters renal function
Dana Hammouri, Andrew Orwick, Mark A Doll, et al.
The Journal of Biological Chemistry
|
February 28, 2013
Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression
Yongqing Liu, Ester Sánchez-Tilló, Xiaoqin Lu, et al.
The Journal of Biological Chemistry
|
December 28, 2013
The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression
Yongqing Liu, Ester Sánchez-Tilló, Xiaoqin Lu, et al.
Cell Stem Cell
|
April 4, 2009
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype
Yongqing Liu, Brian Clem, Ewa K Zuba-Surma, et al.
Molecular Cancer Therapeutics
|
January 19, 2008
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem, Sucheta Telang, Amy Clem, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Experimental and Molecular Pathology
|
May 21, 2009
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Abdullah Yalcin, Sucheta Telang, Brian Clem, et al.
The Biochemical Journal
|
January 25, 2008
The Rb/E2F pathway and Ras activation regulate RecQ helicase gene expression
Yongqing Liu, Shahenda El-Naggar, Brian Clem, et al.
Cancer & Metabolism
|
January 24, 2014
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism
Alden C Klarer, Julie O'Neal, Yoannis Imbert-Fernandez, et al.
Nature Communications
|
October 24, 2013
Rb1 family mutation is sufficient for sarcoma initiation
Yongqing Liu, Ester Sánchez-Tilló, Xiaoqin Lu, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Remote organ cancer adversely alters renal function and induces kidney injury, inflammation, and fibrosis
Dana Hammouri, Andrew Orwick, Mark Doll, et al.
American Journal of Physiology. Renal Physiology
|
December 16, 2024
Remote organ cancer induces kidney injury, inflammation, and fibrosis and adversely alters renal function
Dana Hammouri, Andrew Orwick, Mark A Doll, et al.
The Journal of Biological Chemistry
|
February 28, 2013
Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression
Yongqing Liu, Ester Sánchez-Tilló, Xiaoqin Lu, et al.
The Journal of Biological Chemistry
|
December 28, 2013
The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression
Yongqing Liu, Ester Sánchez-Tilló, Xiaoqin Lu, et al.
Cell Stem Cell
|
April 4, 2009
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype
Yongqing Liu, Brian Clem, Ewa K Zuba-Surma, et al.
Molecular Cancer Therapeutics
|
January 19, 2008
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem, Sucheta Telang, Amy Clem, et al.
Page
of 2